Lumexa Imaging Holdings, Inc. (LMRI) stock
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)
Close on Nov 18, 2026Market cap $1.35BP/E –Yield –
Lumexa Imaging revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $271.97M | +8.2% |
| Q2 FY2026 | Jun 30, 2026 | $264.16M | +7.8% |
| Q1 FY2026 | Mar 31, 2026 | $252.54M | – |
| Q3 FY2025 | Sep 30, 2025 | $258.94M | – |
| Q2 FY2025 | Jun 30, 2025 | $251.40M | – |
| Q1 FY2025 | Mar 31, 2025 | $245.00M | – |
See a number that looks wrong?